154 related articles for article (PubMed ID: 23272541)
1. Human papilloma virus infection and cervical dysplasia.
Melinte-Popescu A; Costăchescu G
Rev Med Chir Soc Med Nat Iasi; 2012; 116(3):853-7. PubMed ID: 23272541
[TBL] [Abstract][Full Text] [Related]
2. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
Melinte-Popescu A; Costăchescu G
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence of human papilloma virus isolated from cervix lesions in a female population from Transilvania].
Feticu L; Bocşan IS; Bondor Cl; Boboş C
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):567-74. PubMed ID: 23077955
[TBL] [Abstract][Full Text] [Related]
5. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
6. [Epidemiology of HPV infections and cervical cancer in Apulia: a survey study and current data analysis].
Martinelli D; Chironna M; Tafuri S; Neve A; Caputi G; Prato R; Germinario C; Quarto M
Ann Ig; 2007; 19(6):499-508. PubMed ID: 18376570
[TBL] [Abstract][Full Text] [Related]
7. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
Lonky NM; Hunter MI; Sadeghi M; Edwards G; Bajamundi K; Monk BJ
J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
[TBL] [Abstract][Full Text] [Related]
9. The association between pregnancy and human papilloma virus prevalence.
Smith EM; Johnson SR; Jiang D; Zaleski S; Lynch CF; Brundage S; Anderson RD; Turek LP
Cancer Detect Prev; 1991; 15(5):397-402. PubMed ID: 1661203
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
11. Primary high-risk HPV screening for cervical cancer in post-menopausal women.
Gyllensten U; Gustavsson I; Lindell M; Wilander E
Gynecol Oncol; 2012 May; 125(2):343-5. PubMed ID: 22293044
[TBL] [Abstract][Full Text] [Related]
12. Association between the evidence of human papilloma virus infection in bladder transitional cell carcinoma in men and cervical dysplasia in their spouses.
Barghi MR; Rahjoo T; Borghei M; Hosseini-Moghaddam SM; Amani D; Farrokhi B
Arch Iran Med; 2012 Sep; 15(9):572-4. PubMed ID: 22924378
[TBL] [Abstract][Full Text] [Related]
13. Cervical human papillomavirus infection in Mexican women with systemic lupus erythematosus or rheumatoid arthritis.
Rojo-Contreras W; Olivas-Flores EM; Gamez-Nava JI; Montoya-Fuentes H; Trujillo-Hernandez B; Trujillo X; Suarez-Rincon AE; Baltazar-Rodriguez LM; Sanchez-Hernandez J; Ramirez-Flores M; Vazquez-Salcedo J; Rojo-Contreras J; Morales-Romero J; Gonzalez-Lopez L
Lupus; 2012 Apr; 21(4):365-72. PubMed ID: 22020266
[TBL] [Abstract][Full Text] [Related]
14. Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection.
Tam LS; Chan AY; Chan PK; Chang AR; Li EK
Arthritis Rheum; 2004 Nov; 50(11):3619-25. PubMed ID: 15529372
[TBL] [Abstract][Full Text] [Related]
15. Distribution of human papillomavirus types, cervical cancer screening history, and risk factors for infection in Manitoba.
Demers AA; Shearer B; Severini A; Lotocki R; Kliewer EV; Stopera S; Wong T; Jayaraman G
Chronic Dis Inj Can; 2012 Sep; 32(4):177-85. PubMed ID: 23046799
[TBL] [Abstract][Full Text] [Related]
16. Type-specific prevalence of Human Papillomavirus infection among women in the Northwest Territories, Canada.
Jiang Y; Brassard P; Severini A; Goleski V; Santos M; Leamon A; Chatwood S; Lys C; Johnson G; Wong T; Kotaska A; Kandola K; Mao Y
J Infect Public Health; 2011 Nov; 4(5-6):219-27. PubMed ID: 22118716
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of human papillomavirus and Chlamydia trachomatis infection among women attending cervical cancer screening in the Republic of Korea.
Oh JK; Franceschi S; Kim BK; Kim JY; Ju YH; Hong EK; Chang YC; Rha SH; Kim HH; Kim JH; Kim CY; Shin HR
Eur J Cancer Prev; 2009 Feb; 18(1):56-61. PubMed ID: 19077566
[TBL] [Abstract][Full Text] [Related]
18. HPV-related cervical disease and oropharyngeal cancer.
Lozza V; Pieralli A; Corioni S; Longinotti M; Bianchi C; Moncini D; Fallani MG
Arch Gynecol Obstet; 2014 Aug; 290(2):375-9. PubMed ID: 24584479
[TBL] [Abstract][Full Text] [Related]
19. Cervical HPV infection in Romanian women infected with HIV during early childhood.
Ene L; Voinea C; Stefanescu C; Sima D; Duiculescu D; Mehta SR
Int J STD AIDS; 2016 Oct; 27(12):1079-1085. PubMed ID: 26404111
[TBL] [Abstract][Full Text] [Related]
20. The clinical significance of HPV screening in premalignant cervical lesions.
Kuyumcuoglu U; Hocaoglu S; Guzel AI; Celik Y
Eur J Gynaecol Oncol; 2010; 31(5):596-7. PubMed ID: 21061813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
